Category Archives: Uncategorized

Cardiac electrophysiologist Ali R. Keramati, MD, a member of the Lankenau Heart Institute at Lankenau Medical Center, has been appointed to serve as a Member of the NCDR EP Registry Steering Committee, part of the American College of Cardiology.   … Continue reading →

Sent on behalf of Barbara Wadsworth and Jon Stallkamp, MD   Colleagues,   Following the FDA’s issuance of an EUA for the Pfizer COVID vaccine, Main Line Health and other hospitals across the country are expecting to receive shipment of … Continue reading →

Effective Friday, Dec 11th Main Line Health labs will convert GC/Chlamydia/HPV testing from Roche Cobas instruments to Hologic Panther instruments. The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in … Continue reading →

By Donna Loyle, communications manager, LIMR   The OPTION clinical trial is a randomized, multicenter study to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to oral anticoagulation following percutaneous catheter ablation for … Continue reading →

Eligible employees who elect to cash in basic leave under the Basic Leave Cash-in Program for 2021 will receive a separate payment on Friday, January 22, 2021.   For your convenience, if you are enrolled in payroll direct deposit you … Continue reading →

Sent on behalf of Barbara Wadsworth and Dr. Jon Stallkamp   Colleagues:   As you have heard on several of our recent town halls, Main Line Health has been working with state and local health officials to obtain the COVID-19 vaccine for our employees … Continue reading →

Effective Dec 8th, 2020 we will switch from Helena electrophoretic system to Sebia electrophoretic system for serum/urine protein electrophoresis, serum/urine immunofixation electrophoresis and hemoglobin electrophoresis. The methodology will remain the same, only instrument will change. As a result of this … Continue reading →

Main Line Health’s FREE six session program to help tobacco users and vapers quit. Click here to view the times and dates to participate via ZOOM.

By Donna Loyle, communications manager, LIMR   Research studies with clinical implications for patients with J Wave syndromes, brain metastases, periprosthetic joint infection and femoropopliteal artery lesions were published in peer-reviewed journals by investigators at the Lankenau Institute for Medical … Continue reading →

By Donna Loyle, communications manager, LIMR   Researchers seeks patients who’ve been diagnosed with limited-stage small cell lung cancer (SCLC) for a clinical trial that is testing treatment with chemotherapy and radiation therapy with the medication Tecenriq® (atezolizumab), or chemotherapy … Continue reading →